Kiadis Poised To Launch Lead Product ATIR101 In 2019

 
• By Sten Stovall
  
Stem cells
ATIR101 is filed in Europe for haploidentical haematopoietic stem cell transplants in patients with blood cancers • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip